GFC Life Science CEO Heecheol Kang Increases Stake by 9,100 Shares in Open Market Purchases, Ownership Rises to 32.68%

CEO Heecheol Kang purchased a total of 9,100 shares in open market transactions from July 13 to 15, 2026, increasing his holdings to 1,740,370 shares.
The purchase prices ranged from KRW 4,616 to KRW 5,524 per share, which are below the current market price of KRW 5,900, indicating a potential undervaluation view.
This acquisition raised his stake from 32.64% to 32.68%, signaling strengthened control and possible confidence in the company's prospects.
[AI Summary]This regulatory filing reports the largest shareholder's voluntary open-market purchases. There is no change in the company's capital structure or dividend policy. The slight increase in ownership may be interpreted as a signal of management confidence, but the financial impact is limited.